LB Pharmaceuticals, Inc. (LBRX) Stock Statistics & Valuation Metrics

LB Pharmaceuticals, Inc. has a market cap or net worth of $967.55M. The enterprise value is $544.53M.

LB Pharmaceuticals, Inc. has 28,676,653 shares outstanding. The number of shares has decreased by -2.65% in one year.

LB Pharmaceuticals, Inc.’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -9.93%.

The current PE Ratio of LB Pharmaceuticals, Inc. is ―. LB Pharmaceuticals, Inc.’s PEG ratio is 0.24.

In the last 12 months, LB Pharmaceuticals, Inc. had revenue of 0.00 and earned -25.20M in profits. Earnings per share was -1.00.

In the last 12 months, operating cash flow was -50.37M and capital expenditures -63.00K, giving a free cash flow of -50.43M billion.

LB Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

LB Pharmaceuticals, Inc. upcoming earnings date is May 12, 2026, Before Open (Confirmed).

LB Pharmaceuticals, Inc. as a current ratio of 41.44, with Debt / Equity ratio of 0.92%

In the past 12 months, LB Pharmaceuticals, Inc. has paid 1.00K in taxes.

LB Pharmaceuticals, Inc. EV to EBITDA ratio is -12.72, with an EV/FCF ratio of -8.98.

LB Pharmaceuticals, Inc. has $365.64M in cash and marketable securities with $3.47M in debt, giving a net cash position of $362.17M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for LB Pharmaceuticals, Inc. is $47.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy